...
首页> 外文期刊>Bali Medical Journal >Relation of risk factors, management, and outcome of preeclampsia patients at Haji Adam Malik Hospital Medan Indonesia 2014-2015
【24h】

Relation of risk factors, management, and outcome of preeclampsia patients at Haji Adam Malik Hospital Medan Indonesia 2014-2015

机译:印度尼西亚棉兰Haji Adam Malik医院2014-2015年子痫前期患者的危险因素,管理和结局之间的关系

获取原文
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: ?Preeclampsia is one of the biggest causal of the maternal dan fetal mortality rate. Preeclampsia has many etiology and patofisiology which is has its own timeline during the pregnancy process. It also has many risk factor such as, age, gravide status etc. In this study, we tried to find any correlation between risk factor, management with the output of the preeclamptic patient during January 2014 to December 2015 ? METHODS: All of the preeclamptic patient who give birth at adam malik general hospital during the period will be included (n=87). The data was collected by their medical record and served in table that correlate between risk factor, management with output of the preeclamptic patient and their fetus (via APGAR).? RESULTS: The most common management is MgSO4 and Nifedipine, with the most delivery path is cesarean section. We didn’t find any significant value between risk factor, management with the output. Age and gravide status 1~(st) minute APGAR (p=0,887) and (p=0,92) 5~(th) minute APGAR (p=0,759) and (p=0,496).? CONCLUSION: The most common management is MgSO4 and nifedipine, cesarean section is the most delivery path. We didn’t find any correlation between APGAR acore and any risk factor.
机译:背景:先兆子痫是母婴死亡的最大原因之一。子痫前期有许多病因和柏菲西学,在怀孕过程中有其自己的时间表。它也具有许多危险因素,例如年龄,重力状态等。在本研究中,我们试图找到2014年1月至2015年12月期间危险因素,管理与先兆子痫患者的输出之间的任何相关性?方法:将包括所有在此期间在亚当·马利克综合医院分娩的先兆子痫患者(n = 87)。这些数据是通过他们的病历收集的,并在表格中列出,这些表格将风险因素,子痫前期患者及其胎儿的输出与管理之间(通过APGAR)联系起来。结果:最常见的治疗方法是硫酸镁和硝苯地平,最常见的分娩途径是剖宫产。在风险因素,管理与输出之间没有发现任何重大价值。年龄和重力状态1〜(分钟)APGAR(p = 0,887)和(p = 0,92)5〜(分钟)APGAR(p = 0,759)和(p = 0,496)。结论:最常见的治疗方法是硫酸镁和硝苯地平,剖宫产是最常见的治疗途径。我们没有发现APGAR acore与任何风险因素之间有任何关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号